glp-1 boom drug set to disrupt food companies GLP-1 use growing in recent

How GLP-1 Medications Became a Regulatory Focus The rapid commercial expansion caught the attention of regulators

M.JungU

Pancreatitis There is a known, although rare, risk of acute pancreatitis with GLP-1RAs

Medical Writing Assistance The authors thank Manthan Mehta, Kumardeep Paul, Syed Rahman, Mansij Biswas, Arpit Jain, Jignesh Ved, from Boehringer Ingelheim (India) medical affairs for providing writing assistance for this manuscript in accordance with Good Publication Practice (GPP3) guidelines ( Authorship All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published

Why not me? said Barden, 34, a Massachusetts-based registered nurse working in mental health and addiction, who has shared her GLP-1 experience as @itsmesashab on TikTok